About
Glimepiride/Metformin is a combination oral antidiabetic medication used for the management of type 2 diabetes mellitus. Glimepiride is a sulfonylurea that primarily works by stimulating insulin release from the pancreatic beta cells. It binds to specific receptors on the beta-cell membrane, leading to depolarization and subsequent influx of calcium, which triggers insulin secretion. This action is glucose-independent and can lead to a risk of hypoglycemia.
Metformin, a biguanide, acts by reducing hepatic glucose production, decreasing intestinal absorption of glucose, and improving insulin sensitivity by enhancing peripheral glucose uptake and utilization. The combination of glimepiride and metformin provides complementary mechanisms of action to achieve better glycemic control than either agent alone, addressing both insulin secretion and insulin sensitivity defects in type 2 diabetes. It is typically used when diet, exercise, and monotherapy with either agent do not provide adequate glycemic control.
Uses
- To improve glycemic control in adults with type 2 diabetes mellitus.
- As an adjunct to diet and exercise when monotherapy with glimepiride or metformin is insufficient.
- As initial therapy in patients with type 2 diabetes when dual therapy is appropriate.
- In patients who have not achieved adequate control on a sulfonylurea or metformin alone.
Directions For Use
Take orally, usually once or twice daily with meals, to minimize gastrointestinal upset and reduce the risk of hypoglycemia.
Benefits
- Provides comprehensive blood glucose lowering.
- Addresses both insulin secretion and sensitivity.
- Effectively reduces HbA1c levels.
- Metformin component can lead to modest weight loss.
- Convenient fixed-dose combination.
- Long-standing efficacy in diabetes management.
Side Effects
- Hypoglycemia
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Headache
- Dizziness
- Metallic taste
- Skin rash
- Lactic acidosis (rare, with metformin)
- Weight gain (with glimepiride)
- Vitamin B12 deficiency (long-term metformin use)
Safety Measures
- Alcohol - Avoid excessive alcohol intake, as it can increase the risk of hypoglycemia (due to glimepiride) and lactic acidosis (due to metformin).
- Pregnancy - Not recommended during pregnancy. Insulin is generally preferred for glycemic control in pregnant women with diabetes.
- Breastfeeding - Not recommended during breastfeeding as both components may pass into breast milk and could cause hypoglycemia in the infant.
- Liver - Contraindicated in severe hepatic impairment due to increased risk of lactic acidosis with metformin and potential for glimepiride accumulation.
- Kidney - Contraindicated in severe renal impairment (eGFR <30 mL/min/1.73 m²) due to metformin accumulation and increased risk of lactic acidosis. Dose adjustment needed for moderate impairment.
- Lung - Use with caution in conditions causing hypoxia (e.g., severe respiratory failure) as it may increase the risk of lactic acidosis.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!